Naturally occurring neuroprotectants in glaucoma

Area of Science:

• Ophthalmology
• Neuroscience
• Pharmacology

Background:

• Glaucoma is a leading cause of irreversible blindness globally.
• Retinal neurodegeneration, particularly of retinal ganglion cells (RGCs), is a hallmark of glaucoma.
• There is a critical need for therapies that offer both early detection and neuroprotection.

Purpose of the Study:

• To explore naturally occurring neuroprotective agents as potential therapies for glaucoma.
• To evaluate the suitability of these agents for clinical application in managing glaucoma.

Main Methods:

• Review of scientific literature on natural compounds with neuroprotective properties.
• Analysis of mechanisms of action, including anti-apoptotic and anti-inflammatory effects.
• Assessment of RGC resilience against insults triggering cell death.

Main Results:

• Several natural agents exhibit significant anti-apoptotic and anti-inflammatory activities.
• These properties enhance the survival and resilience of retinal ganglion cells.
• Potential for these agents to mitigate glaucoma-induced neurodegeneration.

Conclusions:

• Naturally occurring neuroprotective agents hold therapeutic potential for glaucoma.
• Translating these findings into clinical practice requires overcoming specific barriers.
• Further research is needed to optimize delivery and efficacy for glaucoma treatment.